HCA
BLUE

Harbor Capital Advisors’s bluebird bio BLUE Stock Holding History

Harbor Capital Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,992
Closed -$230K – 732
2024
Q1 		$230K Buy
+8,992
New +$230K 0.03% 570
2023
Q3 		– Sell
-189
Closed -$12.5K – 465
2023
Q2 		$12.5K Buy
+189
New +$13.8K ﹤0.01% 631

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harbor Capital Advisors's BLUE Position: Q2 2024 in Review

Harbor Capital Advisors sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 8,992 shares — an estimated $230K sold.

Harbor Capital Advisors first reported a position in BLUE in Q2 2023 and held it in 2 quarters. The position peaked at $230K in Q1 2024. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Harbor Capital Advisors reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 8,992 bluebird bio shares in Q2 2024, an estimated $230K.
  • Harbor Capital Advisors first reported a position in bluebird bio in Q2 2023 and held it in 2 quarters.
  • Harbor Capital Advisors's bluebird bio position peaked at $230K in Q1 2024.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Harbor Capital Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.